Oritavancin - Melinta Therapeutics
At a glance
- Drug Originator Eli Lilly and Company
- Drug Licenced by Hikma Pharmaceuticals; Melinta Therapeutics; Menarini; Xediton Pharmaceuticals
- Drug Class Antibacterials; Glycopeptides; Peptide antibiotics
- Mechanism of Action Cell wall inhibitors
- USA Patent Applicants MELINTA THERAP
- USA Patents 7
- NDAs 2
- International Patents 39
- Patent Applications 114
Table of Contents
Disclaimer